Vaccines · 2023 · 33 citations · 32 references
PharmacyImmunologyInfectious DiseasesImmunizationMolecular VirologyVaccinologyMrna Vaccine TechnologyNucleic Acid VaccinesVaccinationVaccine DeliveryVaccine Delivery SystemsVaccine PlatformsExosomesMilk ExosomesMrna Delivery SystemsMrna Vaccine DesignNanoformulated VaccinesNanoparticle Vaccine FormulationsNanoparticle Vaccine PlatformsVaccine Vector Design
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has presented numerous challenges to global health. Vaccines, including lipid-based nanoparticle mRNA, inactivated virus, and recombined protein, have been used to prevent SARS-CoV-2 infections in clinics and have been immensely helpful in controlling the pandemic. Here, we present and assess an oral mRNA vaccine based on bovine-milk-derived exosomes (milk-exos), which encodes the SARS-CoV-2 receptor-binding domain (RBD) as an immunogen. The results indicate that RBD mRNA delivered by milk-derived exosomes can produce secreted RBD peptides in 293 cells in vitro and stimulates neutralizing antibodies against RBD in mice. These results indicate that SARS-CoV-2 RBD mRNA vaccine loading with bovine-milk-derived exosomes is an easy, cheap, and novel way to introduce immunity against SARS-CoV-2 in vivo. Additionally, it also can work as a new oral delivery system for mRNA.
32
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou, Xing‐Lou Yang, Xian-Guang Wang et al. · Nature · 2020 · 23.3K citations · Full text
Xiaobo Yang, Yu Yuan, Jiqian Xu et al. · The Lancet Respiratory Medicine · 2020 · 10.7K citations · Full text
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici et al. · Cell · 2020 · 9.1K citations · Full text